These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 27531172
21. [Increased levels of auto-antibodies in thyroid diagnostics: Hashimoto thyroidities or Graves disease?]. Paschke R. Internist (Berl); 2006 Nov; 47(11):1193-4. PubMed ID: 17043781 [No Abstract] [Full Text] [Related]
22. Autoantibodies to the TSH receptor. Zakarija M, McKenzie JM. Exp Clin Endocrinol; 1991 May; 97(2-3):165-9. PubMed ID: 1680725 [No Abstract] [Full Text] [Related]
23. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies. Diana T, Wüster C, Kanitz M, Kahaly GJ. J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966 [Abstract] [Full Text] [Related]
24. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE. J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084 [Abstract] [Full Text] [Related]
25. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Morgenthaler NG, Hodak K, Seissler J, Steinbrenner H, Pampel I, Gupta M, McGregor AM, Scherbaum WA, Banga JP. Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678 [Abstract] [Full Text] [Related]
27. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment. Quadbeck B, Hoermann R, Hahn S, Roggenbuck U, Mann K, Janssen OE. Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228 [Abstract] [Full Text] [Related]
32. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Minich WB, Loos U. Exp Clin Endocrinol Diabetes; 2000 Dec; 108(2):110-9. PubMed ID: 10826518 [Abstract] [Full Text] [Related]
33. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease. Bossowski A, Stasiak-Barmuta A, Urban M. Horm Res; 2005 Dec; 64(4):189-97. PubMed ID: 16220002 [Abstract] [Full Text] [Related]
35. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Hermsen D, Liu C, Domberg J, Graeber C, Feldkamp J, Duan Y, Xu K, Liu C, Mao X, Scherbaum WA, Schott M. Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457 [Abstract] [Full Text] [Related]
36. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis]. Roos M, Sjöberg O, Axelsson O, Karlsson FA. Lakartidningen; 2008 Sep; 105(3):120-4. PubMed ID: 18290505 [No Abstract] [Full Text] [Related]